Signal transduction networks and pathological mechanisms of Piezo1 in eye diseases
Abstract
Piezo1 is a non-selective mechanosensitive cation channel and an important molecular transducer of mechanotransduction, which converts extracellular mechanical forces into intracellular biochemical signals to regulate cellular function and tissue mechanical homeostasis. Increasing evidence indicates that Piezo1 is broadly expressed in many ocular organs, including the trabecular meshwork, retina, cornea, lens, and optic nerve. As a key mechanotransducer, Piezo1 converts mechanical stimuli into intracellular signals that affect intraocular pressure homeostasis, aqueous humour dynamics, retinal function, inflammatory response, and tissue remodelling. Mechanical activation of Piezo1 induces Ca2+ influx and downstream signalling cascades (YAP/TAZ, MAPK, NF-κB, NLRP3 pathways) to regulate cellular proliferation, migration, apoptosis, and inflammation. Accumulating evidence suggests a key role of dysregulated Piezo1 signalling in the pathogenesis of several ocular diseases such as glaucoma, diabetic retinopathy, cataracts, dry eye disease, myopia, and corneal disorders. Here we explore the molecular structure and mechanogating processes of Piezo1. It details downstream signalling pathways in ocular tissues and their roles in disease progression. Moreover, this review emphasises the potential of Piezo1-directed therapy to deepen the comprehension of ocular mechanobiology and to promote the development of precision medicine approaches for vision-threatening illnesses.
Related
- Pathological Retinal Oscillations across Retinal Diseases: Shared Circuit Mechanisms and Implications for Photopsia
- Conformational dynamics of an intrinsically disordered receptor enable signal transduction
- Stomatin organizes laterally segregated membrane microdomains to modulate transmembrane transport and signal transduction
- Molecular basis of quorum-sensing signal transduction by CqsS and its inhibition by CqsA, the autoinducer synthase.
- Recent Advances in the Structure and Transduction Mechanisms of PIEZO Channels
BibTeX
@article{wang2026signal,
title = {{Signal transduction networks and pathological mechanisms of Piezo1 in eye diseases}},
author = {Zeyu Wang and Dexuan Wu and Yingjian Sun},
journal = {Frontiers in Molecular Biosciences},
year = {2026},
month = nov,
doi = {10.3389/fmolb.2026.1948576},
url = {https://www.frontiersin.org/articles/10.3389/fmolb.2026.1948576},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Signal transduction networks and pathological mechanisms of Piezo1 in eye diseases
AU - Zeyu Wang
AU - Dexuan Wu
AU - Yingjian Sun
PY - 2026
DA - 2026/11/16
JO - Frontiers in Molecular Biosciences
DO - 10.3389/fmolb.2026.1948576
UR - https://www.frontiersin.org/articles/10.3389/fmolb.2026.1948576
AB - Piezo1 is a non-selective mechanosensitive cation channel and an important molecular transducer of mechanotransduction, which converts extracellular mechanical forces into intracellular biochemical signals to regulate cellular function and tissue mechanical homeostasis. Increasing evidence indicates that Piezo1 is broadly expressed in many ocular organs, including the trabecular meshwork, retina, cornea, lens, and optic nerve. As a key mechanotransducer, Piezo1 converts mechanical stimuli into intracellular signals that affect intraocular pressure homeostasis, aqueous humour dynamics, retinal function, inflammatory response, and tissue remodelling. Mechanical activation of Piezo1 induces Ca2+ influx and downstream signalling cascades (YAP/TAZ, MAPK, NF-κB, NLRP3 pathways) to regulate cellular proliferation, migration, apoptosis, and inflammation. Accumulating evidence suggests a key role of dysregulated Piezo1 signalling in the pathogenesis of several ocular diseases such as glaucoma, diabetic retinopathy, cataracts, dry eye disease, myopia, and corneal disorders. Here we explore the molecular structure and mechanogating processes of Piezo1. It details downstream signalling pathways in ocular tissues and their roles in disease progression. Moreover, this review emphasises the potential of Piezo1-directed therapy to deepen the comprehension of ocular mechanobiology and to promote the development of precision medicine approaches for vision-threatening illnesses.
SN - 2296-889X
ER -